Latest financial market updates and expert analysis
Analysis The numbers tell two completely different stories about Rocket Lab right now, and both of them are true. One version features a company stacking up government contracts at a record...
The numbers landing on Shell’s desk this earnings season tell a story of extraordinary tailwinds. Net income for the first...
European investors have been pouring money into global equity ETFs at an unprecedented clip, yet the MSCI World tracker now...
The Swiss asset manager’s decision to offload its majority holding in Polish convenience-store chain Żabka to Canada’s Alimentation Couche-Tard lands...
The gap between XPeng’s operational momentum and its stock price has rarely been wider. The electric vehicle maker just posted...
For nearly eight years, Alnylam has enjoyed something almost unheard of in biotech: a drug with no true rival for...
The numbers coming out of Cupertino last week were, by any conventional measure, exceptional. Revenue hit a record $109.4 billion...
A company that once promised investors hundreds of autonomous kitchen robots in the field by year-end is now targeting just...
The arithmetic of BioNTech’s share repurchase is straightforward on paper: a program of up to 24.9 million shares, capped at...
The tungsten producer’s journey toward a leaner exchange structure is nearly complete. Almonty Industries has now secured approval to delist...
The arithmetic is jarring. Micron Technology closed Friday at 714.70 euros, down 5.86 percent on the day and 21.71 percent...
